Paul Zhou

2.0k total citations
70 papers, 1.5k citations indexed

About

Paul Zhou is a scholar working on Immunology, Epidemiology and Virology. According to data from OpenAlex, Paul Zhou has authored 70 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 23 papers in Epidemiology and 22 papers in Virology. Recurrent topics in Paul Zhou's work include Immune Cell Function and Interaction (27 papers), HIV Research and Treatment (22 papers) and Influenza Virus Research Studies (18 papers). Paul Zhou is often cited by papers focused on Immune Cell Function and Interaction (27 papers), HIV Research and Treatment (22 papers) and Influenza Virus Research Studies (18 papers). Paul Zhou collaborates with scholars based in United States, China and Hong Kong. Paul Zhou's co-authors include Jason T. Kimata, Abner Louis Notkins, Deepanker Tewari, Chella S. David, Chaobaihui Ye, Weiming Wang, Krishnakumar Devadas, Jingjing Liu, Di Zhang and Simoy Goldstein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Paul Zhou

69 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Zhou United States 22 571 457 435 384 264 70 1.5k
Nikolaus Mueller‐Lantzsch Germany 32 483 0.8× 881 1.9× 1.1k 2.5× 310 0.8× 467 1.8× 63 2.8k
Jenny Hendriks Netherlands 18 1.8k 3.2× 379 0.8× 440 1.0× 141 0.4× 409 1.5× 51 2.8k
A D Lowe United Kingdom 16 261 0.5× 147 0.3× 977 2.2× 588 1.5× 326 1.2× 19 2.1k
Michael W. Melkus United States 16 637 1.1× 191 0.4× 272 0.6× 382 1.0× 332 1.3× 31 1.5k
Marcus Dorner United States 24 596 1.0× 1.1k 2.5× 419 1.0× 245 0.6× 417 1.6× 43 2.5k
Sharof M. Tugizov United States 25 460 0.8× 1.0k 2.3× 277 0.6× 325 0.8× 404 1.5× 54 1.9k
Ross Lindsay United States 13 1.2k 2.1× 581 1.3× 355 0.8× 207 0.5× 458 1.7× 26 1.8k
Victor Levitsky Sweden 17 890 1.6× 625 1.4× 312 0.7× 87 0.2× 258 1.0× 41 1.9k
M Lieberman United States 20 1.3k 2.3× 314 0.7× 573 1.3× 574 1.5× 307 1.2× 42 2.5k
Jonatan Ersching Brazil 16 1.0k 1.8× 286 0.6× 391 0.9× 68 0.2× 204 0.8× 19 1.5k

Countries citing papers authored by Paul Zhou

Since Specialization
Citations

This map shows the geographic impact of Paul Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Zhou more than expected).

Fields of papers citing papers by Paul Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Zhou. The network helps show where Paul Zhou may publish in the future.

Co-authorship network of co-authors of Paul Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Zhou. A scholar is included among the top collaborators of Paul Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Zhou. Paul Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Beibei, et al.. (2023). Response to HIV-1 gp160-carrying recombinant virus HSV-1 and HIV-1 VLP combined vaccine in BALB/c mice. Frontiers in Microbiology. 14. 1136664–1136664. 1 indexed citations
2.
Wu, Xilin, Jia Guo, Mengyue Niu, et al.. (2018). Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice. Journal of Clinical Investigation. 128(6). 2239–2251. 38 indexed citations
3.
Sun, Jianfeng, Guiqin Wang, Teng Zuo, et al.. (2018). Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies. Journal of Biological Chemistry. 293(42). 16503–16517. 9 indexed citations
4.
5.
Huang, Xun, Qianqian Zhu, Xiaoxing Huang, et al.. (2017). In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses. Vaccine. 35(16). 2042–2051. 9 indexed citations
6.
Wang, Guiqin, Shuangshuang Wang, Honglin Chen, et al.. (2016). Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir. mAbs. 8(6). 1156–1166. 10 indexed citations
7.
Batéjat, Christophe, et al.. (2014). Cleavage of Hemagglutinin-Bearing Lentiviral Pseudotypes and Their Use in the Study of Influenza Virus Persistence. PLoS ONE. 9(8). e106192–e106192. 9 indexed citations
8.
Zhou, Fan, Philippe Buchy, Teng Zuo, et al.. (2013). DNA Prime and Virus-like Particle Boost From a Single H5N1 Strain Elicits Broadly Neutralizing Antibody Responses Against Head Region of H5 Hemagglutinin. The Journal of Infectious Diseases. 209(5). 676–685. 13 indexed citations
9.
Yang, Lifei, Yufeng Song, Xiaomin Li, et al.. (2012). HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component. Journal of Virology. 86(14). 7662–7676. 37 indexed citations
10.
Hu, Hongxing, et al.. (2011). High Yield of Human Monoclonal Antibody Produced by Stably Transfected Drosophila Schneider 2 Cells in Perfusion Culture Using Wave Bioreactor. Molecular Biotechnology. 52(2). 170–179. 29 indexed citations
11.
12.
Lee, Seung‐Jae, Reetakshi Arora, Lara Bull–Otterson, et al.. (2006). A Nonneutralizing Anti-HIV Type 1 Antibody Turns into a Broad Neutralizing Antibody When Expressed on the Surface of HIV Type 1-Susceptible Cells. II. Inhibition of HIV Type 1 Captured and Transferred by DC-SIGN. AIDS Research and Human Retroviruses. 22(9). 874–883. 4 indexed citations
13.
Zhou, Paul, Simoy Goldstein, Krishnakumar Devadas, Deepanker Tewari, & Abner Louis Notkins. (1997). Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression. Nature Medicine. 3(6). 659–664. 92 indexed citations
14.
González‐Gay, Miguel Á., Eric Zanelli, Sanjay D. Khare, et al.. (1996). Human leukocyte antigen-DRB1∗1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Human Immunology. 50(1). 54–60. 39 indexed citations
15.
Zaleski, Marek, et al.. (1995). Retrovirus-Induced Lymphoproliferative Disease in Mice: Role of Humoral Immunity in Perinatally Exposed Mice. Immunobiology. 194(4-5). 390–402. 2 indexed citations
16.
Zanelli, Eric, et al.. (1995). Genetic polymorphism of the mouse major histocompatibility complex-associated proteasome subunit Lmp7. Immunogenetics. 41(4). 251–4. 8 indexed citations
17.
Rodriguez, Moses, Naraporn Prayoonwiwat, Paul Zhou, & Chella S. David. (1993). Expression of T cell receptor Vβ transcripts in central nervous system of mice susceptible and resistant to Theiler's virus-induced demyelination. Journal of Neuroimmunology. 47(1). 95–100. 16 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikolaus Mueller‐Lantzsch Breakdown of academic impact, for papers by Jenny Hendriks Breakdown of academic impact, for papers by A D Lowe Breakdown of academic impact, for papers by Michael W. Melkus Breakdown of academic impact, for papers by Marcus Dorner Breakdown of academic impact, for papers by Sharof M. Tugizov Breakdown of academic impact, for papers by Ross Lindsay Breakdown of academic impact, for papers by Victor Levitsky Breakdown of academic impact, for papers by M Lieberman Breakdown of academic impact, for papers by Jonatan Ersching
Rankless by CCL
2026